FDA Approves Tavaborole [Kerydin] Topical Solution for Onychomycosis of the Toenails
July 15, 201 4 – Anacor Pharmaceuticals, Inc on July 8, 2014, announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Kerydin (tavaborole) topical solution, 5%, the first oxaborole antifungal approved for the …
FDA Approves Tavaborole [Kerydin] Topical Solution for Onychomycosis of the Toenails Read more »